Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for Diabetic Macular Edema
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- John A Wells, MD
Palmetto Retina Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
90 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Retina Associates
Tucson, Arizona, United States
- Retina-Vitreous Associates Medical Group
Beverly Hills, California, United States
- Loma Linda University Health Care, Dept. of Ophthalmology
Loma Linda, California, United States
- Southern California Desert Retina Consultants, Mc
Palm Desert, California, United States
- California Retina Consultants
Santa Barbara, California, United States
- Bay Area Retina Associates
Walnut Creek, California, United States
- Retinal Consultants of Southern California Medical Group, Inc.
Westlake Village, California, United States
- New England Retina Associates
Norwich, Connecticut, United States
- Gulf Coast Retina Center
Clearwater, Florida, United States
- Retina Group of Florida
Fort Lauderdale, Florida, United States
- National Ophthalmic Research Institute
Fort Myers, Florida, United States
- Central Florida Retina Institute
Lakeland, Florida, United States
- Ocala Eye Retina Consultants
Ocala, Florida, United States
- Magruder Eye Institute
Orlando, Florida, United States
- Fort Lauderdale Eye Institute
Plantation, Florida, United States
- Sarasota Retina Institute
Sarasota, Florida, United States
- Retina Associates of Florida, P.A.
Tampa, Florida, United States
- Emory Eye Center
Atlanta, Georgia, United States
- Georgia Retina, P.C.
Atlanta, Georgia, United States
- Thomas Eye Group
Atlanta, Georgia, United States
- Southeast Retina Center, P.C.
Augusta, Georgia, United States
- Retina Consultants of Hawaii, Inc.
Honolulu, Hawaii, United States
- Northwestern Medical Faculty Foundation
Chicago, Illinois, United States
- University of Illinois at Chicago Medical Center
Chicago, Illinois, United States
- Northshore University Healthsystem
Glenview, Illinois, United States
- Raj K. Maturi, M.D., P.C.
Indianapolis, Indiana, United States
- John-Kenyon American Eye Institute
New Albany, Indiana, United States
- Medical Associates Clinic, P.C.
Dubuque, Iowa, United States
- Wolfe Eye Clinic
West Des Moines, Iowa, United States
- Retina Associates, P.A.
Shawnee Mission, Kansas, United States
- Retina and Vitreous Associates of Kentucky
Lexington, Kentucky, United States
- Paducah Retinal Center
Paducah, Kentucky, United States
- Elman Retina Group, P.A.
Baltimore, Maryland, United States
- Wilmer Eye Institute at Johns Hopkins
Baltimore, Maryland, United States
- Joslin Diabetes Center
Boston, Massachusetts, United States
- Ophthalmic Consultants of Boston
Boston, Massachusetts, United States
- Vitreo-Retinal Associates, Pc
Worcester, Massachusetts, United States
- Henry Ford Health System, Dept of Ophthalmology and Eye Care Services
Detroit, Michigan, United States
- Retina Vitrous Center
Grand Blanc, Michigan, United States
- Retina Specialists of Michigan
Grand Rapids, Michigan, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2012
- Primary completion
- 31 Oct 2014
- Completion
- 18 Apr 2019
- Last update posted
- 10 Aug 2020
- Registered enrollment
- 660
- Registry id
- NCT01627249
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.